Lv3
268 积分 2024-03-29 加入
An innovative peptide with high affinity to GPC3 for hepatocellular carcinoma diagnosis
1个月前
已完结
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus
1个月前
已完结
Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations
1个月前
已完结
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
5个月前
已完结
STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems
5个月前
已完结
The Rationale for BAFF Inhibition in Systemic Lupus Erythematosus
5个月前
已完结
DB-2304, a Duality Immune Modulating Antibody‒Drug Conjugate (DIMAC) targeting BDCA2, displays strong potency in the suppression of pDC functions
5个月前
已完结
Nonclinical Development of Next-generation Site-specific HER2-targeting Antibody–drug Conjugate (ARX788) for Breast Cancer Treatment
9个月前
已完结
Drug-Linkers in Antibody–Drug Conjugates: Perspective on Current Industry Practices
9个月前
已完结
皖公网安备34019202002308
